Review on the current treatment status of vein of Galen malformations and future directions in research and treatment.

Vein of Galen arteriovenous malformation arteriovenous shunt endothelial cell endovascular embolization gene mutation notch signaling pial arteriovenous malformation shear stress vascular endothelial growth factor

Journal

Expert review of medical devices
ISSN: 1745-2422
Titre abrégé: Expert Rev Med Devices
Pays: England
ID NLM: 101230445

Informations de publication

Date de publication:
Oct 2021
Historique:
pubmed: 24 8 2021
medline: 26 11 2021
entrez: 23 8 2021
Statut: ppublish

Résumé

Vein of Galen malformations (VOGMs) represent a rare pathologic entity with often catastrophic natural history. The advances in endovascular treatment in recent years have allowed for a paradigm shift in the treatment and outcome of these high-flow shunts, even though their pathogenetic mechanisms and evolution remain in part obscure. The overall management of VOGMs requires a tailored case-to-case approach, starting with in utero detection and reserving endovascular treatment for indicated cases. Lately, the advances in translational research with whole-genome sequencing and the coupling with cellular-level hemodynamics attempt to shed more light in the pathogenesis and evolution of these lesions. At the same time the advances in endovascular techniques allow for more safety and tailored technical strategy planning. Furthermore, the advances in MRI techniques allow a better understanding of their vascular anatomy. In view of these recent advances and by performing a PUBMED literature review of the last 15 years, we attempt a review of the evolutions in the imaging, management, endovascular treatment and understanding of underlying mechanisms for VOGMs. The progress in the fields detailed in this review appears very promising in better understanding VOGMs and expanding the available therapeutic arsenal.

Identifiants

pubmed: 34424109
doi: 10.1080/17434440.2021.1970527
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

933-954

Auteurs

Panagiotis Primikiris (P)

Department of Interventional Neuroradiology, Jean Minjoz University Hospital, Besancon, France.

Georgios Hadjigeorgiou (G)

School of Medicine, European University of Cyprus, Nicosia, Cyprus.

Maria Tsamopoulou (M)

School of Medicine, National Kapodistrian University of Athens, Greece.

Alessandra Biondi (A)

Department of Interventional Neuroradiology, Jean Minjoz University Hospital, Besancon, France.

Christina Iosif (C)

School of Medicine, European University of Cyprus, Nicosia, Cyprus.
Department of Interventional Neuroradiology, Henry Dunant Hospital, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH